Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132304) titled 'Comparative Effect of Proton Pump Inhibitors and gastric mucosal protective agents on Acute Graft-versus-Host Disease Post-Transplantation' on Sept. 11.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

Condition: Acute graft-versus-host disease (aGVHD)

Intervention: GMPA group:Intravenous PPI is permitted during the conditioning. From Day 0 through Day +100 post-transplantation, patients will receive oral teprenone.

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-09-15

Target S...